Financial Times Live, the global conferences and events arm of the Financial Times newspaper, gathers pre-eminent public and private sector decision-makers, visionaries and strategists from the world’s most important economies and industries for a wide range of interactive, agenda setting programmes that combine the power of on-site discussion and networking with the flexibility of live-streamed and on-demand broadcasting.
Chaired by senior journalists from the Financial Times and its group publications, the summits, conferences and strategic forums organised by FT Live provide audiences with the opportunity to listen to and interact with speakers of the highest calibre in lively and stimulating debates that cover the key issues of our time.
The Financial Times in 2013 celebrates 125 years as one of the world’s leading global business news organisations. With more than 600 journalists worldwide, the FT has a combined print and online average daily readership of 2.1m people worldwide and a combined paid print and digital circulation of more than 600,000. FT.com has over 5m registered users.
Julphar is a true reflection of Ras Al
Khaimah’s significant development. Established in 1980 under the guidance of
H.H Sheikh Saqr Bin Mohammed Al Qasimi, we have established ourselves as a
leader in production and distribution of pharmaceutical products.
Our goal is to create high-quality
medicines whilst maintaining a competitive cost. We achieve this through a
network of twelve world-class manufacturing plants (with further expansion
planned) and a reliable logistics network which covers five continents.
We maintain a diverse product portfolio
which target major therapeutic segments including endocrinology,
anti-infective, cardiovascular and gastroenterology, over-the-counter,
nephrology, dermatology, respiratory, metabolic and burn and wound management.
Highlighting our commitment to diabetes
management in the region, we have also become the only company in the Middle
East to produce the raw material needed to make insulin through our division
dedicated to Diabetes.
With over 800 products in various dosage
forms and more in the pipeline, Julphar is an example of one of the UAE’s local
businesses making an impact on the global stage.
